Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00726_DB01232> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00726_DB01232 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB01232 label "DDI between Trimipramine and Saquinavir - The strong CYP3A4 inhibitor, Saquinavir, may decrease the metabolism and clearance of Trimipramine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Saquinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB01232]" assertion.
- drugbank_resource:DB00726_DB01232 identifier "drugbank_resource:DB00726_DB01232" assertion.
- drugbank_resource:DB00726_DB01232 title "DDI between Trimipramine and Saquinavir - The strong CYP3A4 inhibitor, Saquinavir, may decrease the metabolism and clearance of Trimipramine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Saquinavir is initiated, discontinued or dose changed." assertion.